|
|
|
|
LEADER |
01000cam a22002652 4500 |
001 |
1745837094 |
003 |
DE-627 |
005 |
20240422234812.0 |
007 |
cr uuu---uuuuu |
008 |
210127s2021 xxk|||||o 00| ||eng c |
020 |
|
|
|a 9780128198414
|c electronic bk.
|9 978-0-12-819841-4
|
020 |
|
|
|a 0128198419
|c electronic bk.
|9 0-12-819841-9
|
035 |
|
|
|a (DE-627)1745837094
|
035 |
|
|
|a (DE-599)KEP060113820
|
035 |
|
|
|a (ELSEVIER)on1204320932
|
035 |
|
|
|a (EBP)060113820
|
040 |
|
|
|a DE-627
|b eng
|c DE-627
|e rda
|
041 |
|
|
|a eng
|
044 |
|
|
|c XA-GB
|
050 |
|
0 |
|a RC280.O8
|
082 |
0 |
|
|a 616.99/465
|
245 |
1 |
0 |
|a Overcoming ovarian cancer chemoresistance
|c edited by Goli Samimi and Christina Annunziata
|
264 |
|
1 |
|a London
|b Academic Press
|c [2021]
|
300 |
|
|
|a 1 Online-Ressource
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
490 |
0 |
|
|a Cancer sensitizing agents for chemotherapy
|v 11
|
500 |
|
|
|a Includes index
|
650 |
|
0 |
|a Ovaries
|x Cancer
|x Chemotherapy
|x Complications
|
650 |
|
0 |
|a Drug resistance in cancer cells
|
650 |
|
2 |
|a Drug Resistance, Neoplasm
|
650 |
|
2 |
|a Ovarian Neoplasms
|x drug therapy
|
650 |
|
2 |
|a Female
|
650 |
|
4 |
|a Ovaries ; Cancer ; Chemotherapy ; Complications
|
650 |
|
4 |
|a Cellules canc�ereuses - R�esistance aux m�edicaments
|
650 |
|
4 |
|a Drug resistance in cancer cells
|
650 |
|
4 |
|a Ovaires - Cancer - Chimioth�erapie - Complications et s�equelles
|
700 |
1 |
|
|a Samimi, Goli
|4 oth
|
700 |
1 |
|
|a Annunziata, Christina
|4 oth
|
776 |
1 |
|
|z 9780128198407
|
776 |
1 |
|
|z 0128198400
|
776 |
1 |
|
|z 0128198400
|
776 |
0 |
8 |
|i Erscheint auch als
|n Druck-Ausgabe
|t Overcoming ovarian cancer chemoresistance
|d [Place of publication not identified] ELSEVIER ACADEMIC Press, 2020
|z 0128198400
|
856 |
4 |
0 |
|u https://www.sciencedirect.com/science/book/9780128198407
|m X:ELSEVIER
|x Verlag
|z lizenzpflichtig
|
912 |
|
|
|a GBV-33-Freedom
|b 2021
|
912 |
|
|
|a GBV-33-EBS-MRI
|
912 |
|
|
|a GBV-33-EBS-ZHB
|
912 |
|
|
|a GBV-33-Freedom
|b 2022
|
912 |
|
|
|a ZDB-33-EBS
|
912 |
|
|
|a ZDB-33-ESD
|
912 |
|
|
|a GBV-33-Freedom
|b 2023
|
912 |
|
|
|a GBV_ILN_105
|
912 |
|
|
|a ISIL_DE-841
|
912 |
|
|
|a SYSFLAG_1
|
912 |
|
|
|a GBV_KXP
|
912 |
|
|
|a SSG-OLC-PHA
|
951 |
|
|
|a BO
|
953 |
|
|
|2 045F
|a 616.99/465
|
980 |
|
|
|2 105
|1 01
|x 0841
|b 4074493152
|h OLR-ELV-TEST
|k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Die Weitergabe an Dritte sowie systematisches Downloaden sind untersagt.
|k Testzugang ZHB Lübeck
|y z
|z 26-02-22
|
981 |
|
|
|2 105
|1 01
|x 0841
|r https://www.sciencedirect.com/science/book/9780128198407
|
995 |
|
|
|2 105
|1 01
|x 0841
|a OLR-ELV-TEST
|